PDCD1 and neoplasm: Since PD-L1 is a ligand of PD-1 and serves an inhibitory signal in PD-1 expressing cells, the expression of PD-L1 in tumor environments is speculated to correlate with better response in patients treated with anti-PD-1 antibodies.